A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Case Medical Research
This is a summary of the European public assessment report (EPAR) for Ovaleap. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Ovaleap. For practical information about using Ovaleap, patients should read the package leaflet or contact their doctor or pharmacist.doi:10.31525/cmr-60fb93 fatcat:vcdp3nfvkfdwpkhqs52z6idpja